ENTX

Entera Bio (ENTX)

About Entera Bio (ENTX)

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Details

Daily high

$2.06

Daily low

$1.75

Price at open

$1.95

52 Week High

$3.22

52 Week Low

$1.50

Market cap

81.2M

Dividend yield

0.00%

Volume

269,475

Avg. volume

85,981

P/E ratio

-7.24

Entera Bio News